Prospective evaluation of insulin resistance among endometrial cancer patients.
Prospective evaluation of insulin resistance among endometrial cancer patients.
复制标题
DOI:
10.1016/j.ajog.2010.11.033
复制
发表时间:
2011-04
影响因子:
9.8
通讯作者:
Lu KH
中科院分区:
文献类型:
--
作者:
Burzawa JK;Schmeler KM;Soliman PT;Meyer LA;Bevers MW;Pustilnik TL;Anderson ML;Ramondetta LM;Tortolero-Luna G;Urbauer DL;Chang S;Gershenson DM;Brown J;Lu KH
Obesity and estrogen are strong risk factors for endometrial cancer (EC). While diabetes also increases risk, little is known about related insulin resistance (IR). The purpose of this study was to determine the prevalence of IR in newly diagnosed EC patients. EC patients from a large, metropolitan county were prospectively enrolled from 2005–2008. Fasting serum was analyzed for glucose and insulin. IR was defined as a history of diabetes or a QUICKI [1/(log fasting insulin + log fasting glucose)] value of <0.357. Among 99 patients, diabetes was present in 30, and an abnormal QUICKI was found in 36 additional patients. Increased risk of IR was significantly associated with higher BMI (p<0.001), lower socioeconomic status (p=0.007), and nulliparity (p=0.029). IR was highly prevalent in endometrial cancer patients, including non-obese women. Better characterization of metabolic risks in addition to obesity may provide avenues for targeted cancer prevention in the future.
登录
查看更多内容
DOI:
10.1016/0002-9378(91)90047-u
发表时间:
1991-12-01
影响因子:
9.8
作者:
NAGAMANI, M;STUART, CA;DOHERTY, MG
通讯作者:
DOHERTY, MG
影响因子:
5.8
作者:
Dal Maso, L;Augustin, LSA;La Vecchia, C
通讯作者:
La Vecchia, C
影响因子:
9.8
作者:
Zhang, Qian;Shen, Qi;Lu, Karen H.
通讯作者:
Lu, Karen H.
DOI:
10.1093/jnci/88.16.1127
发表时间:
1996-08-21
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
Potischman, N;Hoover, RN;Lurain, JR
通讯作者:
Lurain, JR
影响因子:
7.7
作者:
Chen, H;Sullivan, G;Quon, MJ
通讯作者:
Quon, MJ